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Abstract
Many diseases have oxidative stress and inflammation as underlying pathological 
features, including metabolic and inflammatory/autoimmune disorders, diseases of 
the lung, liver, kidney, gastrointestinal tract, cardiovascular and nervous systems. 
A leading physiological mechanism for oxidative stress is the nuclear erythroid-
related factor 2-like 2/antioxidant response element (Nrf2/ARE) signaling pathway. 
It maintains intracellular homeostasis and protects cells from oxidative damage 
by inducing phase II detoxifying and oxidative-stress responsive genes. Nrf2 
transcription factor functions as the key controller of the redox homeostatic gene 
regulatory network, and is tightly controlled by the repressor protein, Kelch-like 
ECH-associated protein 1 (Keap1). Pharmacological agents to inhibit Keap1 and 
boost effectiveness of the Nrf2/ARE pathway have been developed and more are 
in development. This chapter elucidates the importance of hemodynamic laminar 
shear stress in oxidative homeostasis and examines hemodynamic induction of the 
shear stress (SS)/Krupple-like factor2 (KLF2) /Nrf2/ARE pathway as a means to 
combat oxidative stress through hemodynamics.
Keywords: shear stress, mechanotransduction, Nrf2, KLF2, oxidative stress, 
hemodynamics, homeostasis
1. Introduction
In the mid-nineteenth century, Claude Bernard introduced the idea of the “inner 
world” when he theorized that bodily systems function to maintain a constant 
internal environment—what he called the milieu intérieur. A half century later, 
Walter Cannon popularized the concept in his book, Spirit of the Body, wherein he 
coined the word homeostasis, which, “...does not imply something set and immobile, 
a stagnation. It means a condition—a condition which may vary, but is relatively 
constant.” Homeostasis is achieved by constant rebalancing within the body of 
competing mechanisms such as vasodilation vs. vasoconstriction, coagulation 
vs. anti-coagulation, and inflammatory vs. anti-inflammatory elements [1]. This 
 balance of control is usually attained by negative feedback mechanisms [2].
All imbalances of these antagonistic mechanisms lead to heterostasis or disease, 
which are deleterious to the body in some respect. None perhaps is more harmful to 
the body and more likely to lead to morbidity and mortality than excess oxidative 
stress with inadequate antioxidant response. Oxidative stress-based diseases affect 
all parts of the body and manifest themselves through some of the worst diseases 
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which afflict mankind. To compound the problem, these diseases currently have 
only symptomatic relief (Figure 1).
Hemodynamics play a key role in the SS/KLF2/Nrf2/ARE antioxidant pathway 
since its resulting shear stress upregulates both KLF2 and Nrf2 along with other 
antioxidants such as catalase, superoxide dismutase, glutathione peroxidase, 
sirtuin, bilirubin, and others [3, 4]. Each of these substances add to the collective 
antioxidant production generated through this pathway. The SS/KLF2/Nrf2/ARE 
pathway is only a part of a broad biochemical cascade induced by shear stress that 
creates a complex, multifaceted, overlapping and interacting response to oxidative 
stress which contributes to oxidation/reduction (Redox) homeostasis.
2. The endothelium
Endothelial cells (EC) comprise the endothelium, lining the lumen of all blood 
vessels. The endothelium is the largest organ in the human body with a total weight 
comparable to other vital organs and possessing a surface area larger than six tennis 
courts [5]. Once thought of as a passive barrier, now viewed as an organ crucial to 
maintaining vascular health, endothelial dysfunction is an important factor in the ini-
tiation, progression and clinical complication of vascular disease. EC are an integral 
part of tissues and organs. A unique cellular system lining the inside of blood vessels, 
the EC form an interface between circulating blood and the parenchymal cells. EC 
Figure 1. 
Manifestations of oxidative stress. Oxidative stress has been identified as a causative or contributing factor 
in many diseases affecting most of the body’s major organs. Thirty-five examples of oxidative diseases are shown 
for eight organ systems.
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are regulators of hemostasis, vasomotor control, immunological and platelet func-
tions, inflammatory responses, vascular smooth muscle cell growth and migration. 
EC fundamentally control vascular tone by sensing and reacting through secretion 
of transcellular and intracellular signaling molecules. Additionally, the endothelium 
forms an essential vascular barrier for solute transport and osmotic balance [6, 7].
The endothelium is easily overlooked in clinical practice since it does not lend 
itself to evaluation. Compounding the problem is that many physicians are not 
trained in endothelial health. Few textbooks focus on EC and medical school curri-
cula generally lack courses on the endothelium. Additionally, while diseases of other 
organs are associated with measurable biomarkers, endothelial dysfunction has no 
reliable markers. Like other organs in the body, the endothelium is highly complex 
with physiological, biochemical and biomechanical parameters. The endothelium, 
more than most tissues in the body, is adaptive and flexible, responding to the ever-
changing milieu of the local microenvironment.
Unsurprisingly, the EC have a broad potential as therapeutic targets. Since EC 
are strategically located between the blood and tissue, they are rapidly exposed to 
biomolecules, injected pharmacological agents, as well as hemodynamic physical 
forces. Also, the endothelium is highly changeable in size and elasticity in response 
to intrinsic or extrinsic physiological controllers, and thus is amenable to therapeu-
tic intervention while supplying a direct line of communication with every organ in 
the body [8].
3. Hemodynamics, shear stress and mechanotransduction
Mechanical forces guide the form and function of the cardiovascular system, 
whose main role of transporting blood to every tissue in the body is essentially 
physico-mechanical. The stroke volume generates hemodynamic forces on the 
arterial vasculature: wall shear stress, hydrostatic pressures and cyclic stretch 
[9]. Laminar SS, the more important of these forces, is a tangential force arising 
due to the dragging friction of blood elements with the vessel wall. SS will vary 
from a low of ~1 dyne/cm2 in veins up to >50 dyne/cm2 in arterial vessels [10]. 
Hemodynamically driven blood flow and SS produce EC mechanotransduction, a 
group of events whereby a cell can actively sense, integrate, and convert a physi-
cal stimulus into electrical and biochemical signals [11]. These forces are sensed 
and interpreted by EC in the luminal vessel wall to: a) guide development during 
embryogenesis and remodeling during postnatal and adult life; b) optimize blood 
flow to the tissues and; c) ensure mechanical integrity of the vessel walls. These SS 
signals bring about intracellular changes, such as activation of signaling pathways 
and transcriptional regulation that modify gene and protein expressions as well as 
endothelial phenotype and function [12]. Shear stress-induced mechanotransduc-
tion influences key molecules and signaling pathways that lead to the changes in cell 
functions and behavior.
EC are exposed to fluid forces of greater magnitude than those experienced by 
other tissues. The mechanically related responses controlled by the endothelium are 
most important in the control of vascular tone in regulating blood flow. The prin-
cipal functions of endothelium include: a) maintenance of anticoagulant proper-
ties; b) regulation of vascular permeability; c) control of vessel diameter; and d) 
responses to pathological consequences associated with inflammation, wound 
healing, and cardiovascular disorders.
Hemodynamic factors in these processes can influence endothelial anatomy and 
function either by the direct action of shear stress and other stretch forces on the 
endothelium or by indirect modification of the local concentrations of chemicals 
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and agonists at the endothelial surface (Figure 2). The mechanisms may have 
overlapping actions such as direct forces acting on surface enzymes while receptors 
concurrently modify enzyme-substrate and agonist-receptor interactions while one 
or both can be influenced by convective or diffusive transport [13].
It has been shown that EC-induced gene expression is important in hemostasis, 
thrombosis, growth regulation and proinflammatory activation and is transcrip-
tionally regulated by mechanotransduction [4]. Many of these activated regulatory 
genes are directly involved in EC adhesion (e.g., ICAM-1). These observations 
suggest a novel paradigm linking biomechanical stimulation with endothelial 
activation. Studies have revealed the existence of shear stress response elements 
(SSRE) in the promoters of physiologically relevant genes such as the platelet-
derived growth factor (PDGF), endothelial nitric oxide synthase (eNOS) and 
vascular cellular adhesion molecule (VCAM-1), that act to up- or down-regulate 
gene transcription.
One of the key shear stress-generated endothelial molecules is eNOS. This 
enzyme generates nitric oxide (NO) from L-arginine and O2. NO regulates EC sur-
vival, vascular tone (vasodilation), angiogenesis and possesses anti-inflammatory 
and antioxidant properties [14].
Figure 2. 
The hemodynamic oxidation regulation pathway. Hemodynamic shear stress and mechanotransduction 
create a cascade of complex, interacting events which induce dozens of physiologically active substances. Some 
are brought about through the SS/KLF2/Nrf2/ARE pathway, others are through direct autocrine and paracrine 
pathways.
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To date, few have attempted to use hemodynamics, to counter excess oxidative 
stress. This is in part due to a shortage of methods with which to engage the body 
hemodynamically. Existing therapeutic methods of increasing blood flow suf-
ficiently to generate therapeutic levels of shear stress include: exercise, electrical 
stimulation, external counter pulsation (ECP), periodic acceleration, and simulated 
(passive) skeletal muscle exercise.
Exercise is an excellent therapy to combat oxidative stress even though it gener-
ates reactive oxygen species (ROS). Unfortunately, most patients in need of this 
therapy either cannot, or will not, comply with prescriptive exercise needed to 
reach therapeutic levels of SS. Electrical stimulation has been used for years to 
simulate exercise with good success, but the field suffers from confusing heteroge-
neity. There is an overwhelming number of electrical stimulators in the market with 
differences in voltage, current, waveform, protocol, size and number of electrodes 
employed. Also, there are not many randomized clinical trials of electrical stimula-
tion with statistically validated results. Other alternatives to exercise include a 
simulated jogging device that provides passive cycles of leg movement resulting in 
an increased level of blood flow and shear stress in the legs. There are also external 
counter pulsation (ECP) devices that produce SS. Their use, however, is currently 
limited to treating angina pectoris and heart failure. ECP consists of pneumatic 
cuffs placed on legs and lower torso with cyclic inflations and deflations that are 
timed to the patient’s heartbeat such that cuffs inflate at the beginning of diastole 
and deflate at the beginning of systole. In theory, this action increases the number 
of pulses in the circulation thereby producing additional SS. Lastly, SS has been 
increased through a motorized bed that has a reciprocating motion, creating back-
and-forth movement of blood flow. This therapy, known as whole-body periodic 
acceleration, does not increase blood circulation, however it does increase levels 
of shear stress [15]. The use of hemodynamics as a therapy, despite today’s lack 
of strong evidence, appears to hold promise, with Fledderus and colleagues [16] 
finding that, “Physiological levels of shear stress will induce activation and nuclear 
translocation of Nrf2, and Nrf2-dependent cytoprotective gene expression.” They 
also found that “SS generated KLF2 primes the activation of the Nrf2 pathway by 
inducing nuclear localization of Nrf2”.
4. Oxidative stress and homeostasis
Excessive, chronic oxidative stress has been implicated in the development and 
exacerbation of diseases affecting most of the body’s major organs, including cancer, 
diabetes, autoimmune, cutaneous, neurodegenerative, pulmonary and cardiovascu-
lar diseases, infection, inflammation, and aging (Figure 1). Endogenous oxidative 
stressors normally result from metabolic processes involving mitochondria. Chronic 
exposure to excess reactive oxygen species causes cellular and macromolecular dam-
age [17]. Oxidative stress is the result of an imbalance of pro-oxidant and antioxidant 
substances that lead to the generation of toxic ROS, such as hydrogen peroxide, nitric 
oxide, superoxide, hydroxyl radicals and others [18]. The production of ROS is usu-
ally in balance with homeostatic antioxidant enzymes such as superoxide dismutase 
(SOD), catalase (CAT) and glutathione peroxidase (Gpx). In vivo studies have found 
that most oxidative damage occurs from reduced levels of antioxidants rather than 
increased ROS production [19]. Adequate levels of both are considered to be essential 
for normal cell function. Mitochondria create their own antioxidants to balance their 
generation of ROS, such as manganese SOD (Mn-SOD) which converts O2•- to H2O2 
which is further reduced by CAT and Gpx to harmless H2O and O2. Importantly, 
CAT, Gpx, and SOD are essential antioxidants that are hemodynamically upregulated 
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in response to physiological levels of endothelial SS [20, 21]. The Copper/zinc-SOD 
(Cu/Zn-SOD) antioxidant, which is also upregulated in response to shear stress, 
plays a role in stabilizing O2•- and contributes to the homeostatic redox state. 
Antioxidant defenses are extremely important as they eliminate free radicals, thereby 
providing biological protection. These systems not only defend against the problems 
of oxidative damage but are essential for disease prevention [22].
Oxidant and antioxidant signaling are both features of oxidative homeostasis, 
which is the maintenance of nucleophilic tone and a healthy physiological steady 
state. Redox imbalance is rapidly reversed by feedback reactions, maintained by con-
tinuous signaling for production and elimination of electrophiles and nucleophiles, 
thus maintaining homeostasis [23]. The production of oxygen free radicals some-
times exceeds the capacity of the endogenous antioxidant system and oxidative stress 
occurs as well as cellular injury. Oxygen free radicals can cause cellular membrane 
lipid peroxidation and protein oxidation which leads to disruption of cellular integ-
rity. In addition, apoptosis and autophagy, resulting from oxidative stress, represent 
important mechanisms that can lead to the destruction of cells in many systems [24].
Hemodynamic SS is a key modulator of the body’s response to oxidative stress. 
Physiological levels of laminar SS, ~12 to 15 dynes/cm2, as in laminar arterial flow, 
promote EC survival and quiescence, alignment of EC in the direction of flow, 
and secretion of substances that reduce oxidation and coagulation while allowing 
Figure 3. 
Effects of shear stress on endothelium. Biochemical changes brought about through hemodynamics, shear 
stress and mechanotransduction can have both beneficial and destructive consequences throughout the 
body. Generally, low or disturbed flow and SS lead to endothelial dysfunction and disease, while normal 
physiological flow helps maintain endothelial homeostasis.
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vasodilation to increase flow. In contrast, low SS, or turbulent flow and other atypi-
cal flow patterns that involve changes in direction and magnitude of flow with shear 
stress <5 dynes/cm2, promote ROS generation, adhesive and inflammatory mol-
ecules, vasoconstrictors, endothelial proliferation and apoptosis (Figure 3) [24–26].
5. Shear stress induced Nrf2
Nrf2, a basic leucine zipper (bZIP) transcription factor is widely expressed and 
can be found in many organs and tissues such as the kidney, muscle, lung, heart, 
liver and brain [25]. The CNC family of proteins regulates gene expression, tissue 
differentiation and development in a variety of organs. Nrf2, perhaps the most 
studied of the CNC family, is responsible for the expression of phase II enzymes 
and a number of endogenous antioxidants including ARE-mediated processes that 
induce the activation of antioxidative enzymes and detoxifying enzymes, including 
heme oxygenase 1 (HO-1), quinone oxidoreductase (NQO1), nicotinamide adenine 
dinucleotide phosphate (NAD(P)H), and glutathione-S-transferase (GST) [26, 27].
Under basal conditions, the amount of Nrf2 is low due to its continuous sequestra-
tion by KEAP1 and subsequent proteasomal degradation. In this homeostatic state, 
Nrf2 is continuously ubiquitinated and targeted for proteasomal degradation by 
Kelch-like (ECH)-associated protein 1 (KEAP1). Electrophiles from endogenous and 
exogenous sources or other small molecules which can activate Nrf2 are thus able to 
do so by inactivating KEAP1 or by disrupting the KEAP1-Nrf2 binding interface [17]. 
Shear stress generated KLF2 induces nuclear translocation of the Nrf2 which leads to 
more Nrf2-ARE interactions and production of antioxidant agents (Figure 4).
The transcription factor that functions as the key controller of the redox homeo-
static gene network, Nrf2 has roles in metabolic reprogramming, proteostasis, 
autophagy, unfolded protein response, mitochondrial biogenesis. Inflammation, 
and immunity. Through this complex regulatory network, Nrf2 appears to function 
as a truly pleiotropic transcription factor [28, 29].
Together, more than 500 Nrf2 target genes have varying roles in mounting cel-
lular defenses through encoding a large network of proteins, some of which catalyze 
phase I, II and III cytoprotective detoxification, while others are antioxidant and 
anti-inflammatory agents [30]. Nrf2 plays a large role in controlling cellular redox 
homeostasis through the regulation of key enzymes and proteins involved in 
synthesis, utilization and regeneration of glutathione (GSH), thioredoxin (TXN), 
peroxiredoxin and NADPH [31]. The activities of Nrf2 are a major determinant of 
the cellular redox state.
Under basal conditions, the amount of Nrf2 is low due to its continuous seques-
tration by KEAP1 and subsequent proteasomal degradation. In homeostatic condi-
tions, Nrf2 is continuously ubiquitinated and targeted for proteasomal degradation 
by Kelch-like (ECH)-associated protein 1 (KEAP1). Electrophiles from endogenous 
and exogenous sources or other small molecules which can activate Nrf2 are thus 
able to do so by inactivating KEAP1 or by disrupting the KEAP1-Nrf2 binding 
interface [32]. Shear stress generated KLF2 induces nuclear translocation of the Nrf2 
which leads to more Nrf2-ARE interactions and production of antioxidant agents.
Exposure to toxicants or ROS from oncogenic signaling, genetic mutations, 
chronic wounds, autophagy disruption, or metabolic alterations disrupt the KEAP1-
Nrf2 complex leading to proteasomal degradation of Keap1 and the translocation 
and activation of Nrf2. KLF2 substantially enhances antioxidant activity of Nrf2 
by inducing its nuclear localization and activation [16]. Nrf2 translocates into the 
nucleus where it heterodimerizes with a small musculoaponeurotic fibrosarcoma 




The SS/KLF2/Nrf2/ARE pathway. Shear stress upregulates KLF2 which induces the nuclear translocation 
and activation of Nrf2, while, concurrently, free radicals break Keap1-Nrf2 binding and lead to its 
degradation. Nrf2 interacts with ARE to upregulate a broad array of antioxidant elements. 
Figure 5. 
The SS/KLF2/Nrf2/ARE cardioprotective pathway. Showing the effects of the SS/Nrf2/LKF2/ARE 
pathway in cardiovascular health. The chart will be very similar for all diseases of oxidative stress.
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factors and cofactors to regulate its target genes, encoding proteins involved in 
antioxidants, detoxification, metabolism, and inflammation (Figure 5) [8, 17].
Since Nrf2 helps protect cells from oxidative damage, it aids in preventing major 
diseases. Several reports have shown the importance of the Keap1–Nrf2 system as a 
therapeutic target for many neurodegenerative diseases and even cancer. As a con-
sequence, academia and the pharmaceutical industry have been investigating the 
Keap1–Nrf2 system attempting to increase Nrf2. Several pharmacolgical inhibitors 
of Keap1 have been developed to boost the effectiveness of the Nrf2/ARE pathway.
Several studies have documented the age-related decline of Nrf2. On the other 
hand, Narashimhan and Rajasekaran, [33] as well as Grounder and colleagues [34] 
found that simulated exercise in murine examples using electrical stimulation 
resulted in significant improvement in Nrf2 levels. In the case of Grounder’s group, 
after six weeks of simulated moderate exercise, the aged group improved their Nrf2 
levels to nearly equal those of the young group. It would seem, in light of this, that 
age is not the problem: lack of hemodynamic flow is the problem.
6. Shear stress generated KLF2
KLF2 is induced by SS and for more than twenty years SS importance in endo-
thelial medicine has been steadily growing. Initially, there were investigations into 
whether KLF2 was an essential regulator of endothelial and organ system survival. 
Investigators demonstrated that KLF2 expression is increased during laminar flow 
in homeostasis and is reduced because of low or turbulent flow or cytokine storm. 
KLF2 promotes EC health through a profile of >1,000 target genes and suppresses 
inflammation in part through its competition with NFkB for critical transcrip-
tional co-factors (Figure 6). KLF2 also promotes transcription of anti-thrombotic 
Figure 6. 
Pleiotropic effects of KLF2. CNP, C-natriuretic peptide; ET-1, endothelin-1; ASS, arginosuccinate synthase; 
AM, adrenomedullin; ACE, angiotensin converting enzyme; TM, thrombomodulin; APC, activated protein C; 
PAI-1, plasminogen activator inhibitor-1; eNOS, endothelial nitric oxide synthase; PAR-1, protease-activated 
receptor 1; TF, tissue factor; CD40L, CD40 ligand; MMP, matrix metalloproteinase; MCP-1, monocyte 
chemotactic protein 1; IL-6=8, interleukin 6=8; CD62L, CD62 ligand; S1P, sphingosine-1 phosphate; IL-4, 
interleukin-4; Nrf2, nuclearfactor erythroid 2-like; NQO1, NAD(P)H: quinine oxidoreductase-1; HO-1, heme 
oxygenease-1; MAPK, mitogen-activated protein kinase; P-actin BP, phosphorylated actin binding protein; 
VCAM, vascular cell adhesion molecule;ATF2, activating transcription factor 2; AP-1, activator protein 
1; SMAD, Sma and Mad related protein; Ang, angiopoetin; SEMA3F, semaphorin 3F; HIF-1a, hypoxia-
inducible factor 1 alpha [35].
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genes, further lending to its vasoprotective role. Endothelial KLF2 acts as a 
master controller promoting EC quiescence and integrity through its effects in 
multiple transcriptional networks [36]. In physiological conditions, the vascular 
endothelium is largely maintained in a quiescent and impermeable state by the 
constitutive activity of KLFs and the mechanosensory proteins VE-cadherin and 
platelet endothelial cell adhesion molecule-1 (PECAM-1). Upregulation of KLF2 
results in the upregulation of Nrf-2 and eNOS together with concomitant inhibi-
tion of mitochondrial ROS production while inhibiting the transcriptional activity 
of NF-κB,
C-type natriuretic peptide (CNP), an autocrine and paracrine mediator is 
potently induced by KLF2 in cardiomyocytes and fibroblasts. It regulates a number 
of vital physiological functions in the cardiovascular system [37]. Circulating 
biomarkers of healthy endothelial function would be useful to detect the earliest 
deficiencies in endothelial function. CNP is an endothelial paracrine factor that has 
been implicated in endothelial-dependent vasodilation in certain vascular beds, 
in addition to suppressing neointimal hyperplasia. CNP acts on adjacent vascular 
smooth muscle cells by impinging on the cyclic guanosine monophosphate (cGMP) 
pathway that is also responsive to NO. Parmar and colleagues demonstrated that 
CNP is induced by statins in a KLF2-dependent manner which indicates that this 
molecule could be a possible biomarker of EC [38].
7. Other shear stress- generated antioxidants
The role of hemodynamics in oxidative homeostasis is of major importance. The 
SS/KLF2/Nrf2/ARE pathway is powerful and important, but hemodynamically 
driven SS produces additional synergistically acting and interacting antioxidants 
that can help restore redox balance. The body’s endogenous antioxidant defense 
system relies on a complex group of enzymatic and nonenzymatic antioxidants that 
act against free radicals to blunt or block their pathological effects. The hemody-
namically regulated antioxidants discussed below, including superoxide dismutase 
(SOD), catalase (CAT), glutathione peroxidase (GPX), heme oxygenase-1 (HO1), 
thioredoxin (TRX), and sirtuin (SIRT1), are indispensable in the defense against 
oxidative stress. These antioxidants are in continuous action to balance against 
ROS which are continuously generated in normal body metabolism, in particular 
through the mitochondrial energy production pathway.
7.1 Superoxide dismutase (SOD)
The first detoxification enzyme and the most powerful antioxidant in the body is 
SOD. It is an antioxidant enzyme that acts as the body’s first line of defense against 
ROS. SOD catalyzes the dismutation of two molecules of superoxide anion to hydro-
gen peroxide (H2O2) and molecular oxygen (O2), rendering the superoxide anion 
less toxic (the H2O2 is further reduced by CAT and GPx). SOD is a metalloenzyme 
and has a metal cofactor for its activity. Three isoforms of the enzyme are identified 
as 1. copper/zinc (Cu/Zn SOD), 2. manganese (Mn SOD), and 3. iron (Fe/SOD) also 
known as extracellular (EC/SOD) [39, 40].
7.2 Catalase (CAT)
Catalases are enzymes that can neutralize hydrogen peroxide, a ubiquitous 
oxidant. The enzyme catalyzes the dismutation of two molecules of hydrogen 
peroxide into one molecule of oxygen and one molecule of water. CAT has a very 
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high turnover rate: one catalase enzyme can convert 40 million molecules of 
hydrogen peroxide to oxygen and water per second. This enzyme is necessary 
for survival as it prevents hydrogen peroxide from accumulating to dangerous 
levels. Hydrogen peroxide at high levels in the body can induce cellular damage 
[41, 42].
7.3 Heme oxygenase-1 (HO1)
The antioxidant effects of HO-1 consist of its ability to increase glutathione 
levels and to degrade heme, as well as to induce biliverdin and bilirubin, both of 
which have potent antioxidant properties. Biliverdin is a tetrapyrrolic, water-
soluble compound formed when heme is broken down into biliverdin, carbon 
monoxide and iron by heme oxygenase. Biliverdin is anti-mutagenic, antioxidant, 
anti-inflammatory, and immunosuppressant [43, 44].
7.4 Glutathione peroxidase (GPx)
Hemodynamic shear stress strongly upregulates the GPx family of extracel-
lular antioxidant proteins that catalyze the reduction of hydrogen peroxide and 
lipid hydroperoxides into water and alcohols. Sometimes, its activity depends on 
selenium as a cofactor, and for this reason, it is often referred to as a selenocysteine 
peroxidase. GPx fills a crucial role by inhibiting the lipid peroxidation process to 
protect cells from oxidative stress [45, 46].
7.5 Thioredoxin (TRX)
The Trx system, which includes NADPH, thioredoxin reductase (TrxR), and 
TRX, is an important system defending against oxidative stress through its disulfide 
reductase activity regulating protein dithiol/disulfide balance. The cytosolic and 
mitochondrial Trx systems, in which TrxRs are high molecular weight seleno-
enzymes, in concert with the glutathione-glutaredoxin (Grx) system (NADPH, 
glutathione reductase, GSH, and Grx) control cellular redox [47, 48].
7.6 Sirtuin (SIRT1)
SIRTs are a family of nicotinamide adenine dinucleotide (NAD)-dependent 
histone deacetylases with the ability to deacetylate histone and nonhistone targets 
and is linked to cellular metabolism, the redox state and survival pathways. SIRT1 
deficiency in endothelial cells (ECs), vascular smooth muscle cells and monocytes/
macrophages contributes to increased oxidative stress, inflammation, foam cell 
formation, senescence and impaired nitric oxide production. It is well established 
that endogenous NO generated from eNOS plays a crucial role in maintaining 
vascular function and homeostasis, which facilitates vascular tone, leukocyte 
adhesion, smooth muscle cell proliferation and migration, and platelet aggregation. 
Previous studies have shown that endogenous NO serves as an anti-atherosclerotic 
and anti-aging factor and that SIRT1 in endothelial cells regulates NO produc-
tion. SIRT1 may play a crucial role in reducing inflammation and oxidative stress. 
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) 
deacetylation by SIRT1 reduces oxidative stress through expression of antioxidant 
enzymes, including Mn-SOD. Additionally, Forkhead box protein O3a (FOXO3a) is 
deacetylated by SIRT1 and translocates to the nucleus, resulting in the upregulation 
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8. Conclusions and further perspectives
The restoration of normal hemodynamics can provide a viable solution for 
the debilitating diseases that result from oxidative stress (Figure 1). While it may 
seem unlikely, the body has a large, complex, and robust antioxidant system with 
overlapping and synergistic actions. All those systems, however, are contingent 
upon hemodynamic activation of endocrine, autocrine and paracrine systems to 
restore the enzymes, proteins, genes, and other antioxidants essential for redox 
homeostasis. Numerous in vivo studies indicate that oxidative damage occurs 
from reduced levels of antioxidant enzymes rather than increased production of 
ROS. The utilization of hemodynamic forces and shear stress-initiated endothelial 
mechanotransduction to increase antioxidant enzymes is evident in the literature 
and warrants further investigation. The development of means and methods that 
enhance normal hemodynamics is also needed.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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